In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prosonix Ltd.

Division of Circassia Pharmaceuticals PLC
www.prosonix.co.uk

Latest From Prosonix Ltd.

Mite Trial Failure 'The Final Straw' As Circassia Ends Anti-Allergy Investing

Circassia has thrown in the towel on investing in anti-allergy vaccines and will focus now on respiratory activities, after its house dust mite allergy study missed its primary endpoints.

Business Strategies Clinical Trials

Circassia's Harris Deeply Frustrated By Phase III Cat Allergy Flop

The UK biotech’s potential revolutionary approach to allergies has failed to achieve its primary endpoint in a Phase III study, halting much of its research in the allergy area and casting a shadow over UK innovation.

Clinical Trials Research & Development

Biopharma Quarterly Dealmaking Statistics, Q2 2015

Q2 biopharma financing reached $15.4 billion, a slight increase over the previous quarter; leading the M&A activity was CVS' $11.8 billion buy of Omnicare; and AstraZeneca and Juno were the two most active dealmakers in cancer immunotherapy, a popular therapeutic focus of Q2 alliances.

BioPharmaceutical Deals

Allergy Therapeutics To Enter U.S. Allergy Market With 2019 Launch

Launch of the first FDA-approved subcutaneous allergy vaccine may be four years away, but the European specialty company is starting to plan for commercialization and market growth.

BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
    • Generic Drugs
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Circassia Pharmaceuticals PLC
  • Senior Management
  • David Hipkiss, CEO
    Andy Bush, COO & CFO
    Geoff Down, CMO
    Cecile Miles, CBO
  • Contact Info
  • Prosonix Ltd.
    Phone: 1865 784250
    Robert Robinson Ave., Magdalen Centre
    Oxford Science
    Oxford, OX4 4GA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register